77 Results

People

  1. Zauber
    Zauber
  2. Boyle
    Boyle
  3. Ilson
    Ilson
  4. Dickler
    Dickler
  5. Hsu
    Hsu
  6. Hudis
    Hudis
  7. Abrey
    Abrey
  8. Casper
    Casper
  9. Cheung
    Cheung
  10. Kushner
    Kushner

Groups

  1. Department of Medicine (28)
  2. Survivorship Research (25)
  3. Solid Tumor Oncology Division (18)
  4. Population Sciences Research Program (17)
  5. Epidemiology and Biostatistics (14)
  6. Surgery (14)
  7. Epidemiology Service (13)
  8. Division of Subspecialty Medicine (9)
  9. Gastrointestinal Oncology Service (9)
  10. Center for Pancreatic Cancer Research (6)
  1. "celecoxib"
Formats
  1. Journal Article (73)
  2. Conference Paper (2)
  3. Editorial (1)
  4. Review (1)
Groups
  1. Department of Medicine (28)
  2. Survivorship Research (25)
  3. Solid Tumor Oncology Division (18)
  4. Population Sciences Research Program (17)
  5. Epidemiology and Biostatistics (14)
  6. Surgery (14)

More Groups

People
  1. Ann Zauber (13)
  2. David Ilson (5)
  3. Jay Boyle (5)
  4. Clifford Hudis (3)
  5. Maura Dickler (3)
  6. Meier Hsu (3)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (1)
  4. 2020 (1)
  5. 2019 (1)
  6. 2018 (1)

More Years

Publications
  1. Cancer Prevention Research (6)
  2. Clinical Cancer Research (5)
  3. New England Journal of Medicine (4)
  4. The Oncologist (4)
  5. Journal of Neuro-Oncology (3)
  6. Journal of the National Comprehensive Cancer Network (3)

More Publications

Publishers
  1. American Association for Cancer Research (12)
  2. Elsevier Inc. (12)
  3. Springer (8)
  4. Lippincott Williams & Wilkins (6)
  5. Oxford University Press (6)
  6. Elsevier Science, Inc. (4)

More Publishers

Results (77)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The emerging role of anti-angiogenic strategies in hematological malignancies
    Journal Article

    Bompais-Vincent, H.; Vincent, L.
    Hématologie (2009)

    Fulltext@MSK | Save
  • Prostaglandin inhibition and cardiovascular risk: Maybe timing really is everything
    Journal Article

    Bertagnolli, M. M.; Zauber, A. G.; Solomon, S.
    Cancer Prevention Research (2009)

    Fulltext@MSK | Save
  • Five-year efficacy and safety analysis of the adenoma prevention with celecoxib trial
    Journal Article

    Bertagnolli, M. M.; Eagle, C. J.; Zauber, A. G.; Redston, M.; Breazna, A.; Kim, K.; Tang, J.; Rosenstein, R. B.; Umar, A.; Bagheri, D.; more...
    Cancer Prevention Research (2009)

    Fulltext@MSK | Save
  • Pilot randomized phase II study of celecoxib in oral premalignant lesions
    Journal Article

    Papadimitrakopoulou, V. A.; William, W. N. Jr; Dannenberg, A. J.; Lippman, S. M.; Lee, J. J.; Ondrey, F. G.; Peterson, D. E.; Feng, L.; Atwell, A.; El-Naggar, A. K.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: Possible leukemogenic role of temozolomide
    Journal Article

    Kushner, B. H.; LaQuaglia, M. P.; Kramer, K.; Modak, S.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2008)

    Fulltext@MSK | Save
  • Investigational therapies for metastatic thyroid carcinoma
    Journal Article

    Tuttle, R. M.; Leboeuf, R.
    Journal of the National Comprehensive Cancer Network (2007)

    Fulltext@MSK | Save
  • Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas - Authors' reply
    Journal Article

    Solomon, S. D.; Pfeffer, M. A.; Finn, P. V.; Bertagnolli, M. M.; McMurray, J. J. V.; Levin, B.; Eagle, C.; Lechuga, M. J.; Hawk, E.; Zauber, A. G.; more...
    Circulation (2007)

    Fulltext@MSK | Save
  • Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomas
    Journal Article

    Shah, G. D.; Silver, J. S.; Rosenfeld, S. S.; Gavrilovic, I. T.; Abrey, L. E.; Lassman, A. B.
    Journal of Neuro-Oncology (2007)

    Fulltext@MSK | Save
  • Fatal hepatorenal failure and thrombocytopenia with SU5416, a vascular endothelial growth factor Flk-1 receptor inhibitor, in AIDS-Kaposi's sarcoma
    Journal Article

    Noy, A.; Von Roenn, J.; Politsmakher, A.; Miles, S.; Bernd, C.
    AIDS (2007)

    Fulltext@MSK | Save
  • Trastuzumab - Mechanism of action and use in clinical practice
    Journal Article

    Hudis, C. A.
    New England Journal of Medicine (2007)

    Fulltext@MSK | Save